Didier Jutras‐Aswad

ORCID: 0000-0002-8474-508X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cannabis and Cannabinoid Research
  • Substance Abuse Treatment and Outcomes
  • Opioid Use Disorder Treatment
  • HIV, Drug Use, Sexual Risk
  • Prenatal Substance Exposure Effects
  • Neurotransmitter Receptor Influence on Behavior
  • Hepatitis C virus research
  • Bipolar Disorder and Treatment
  • Homelessness and Social Issues
  • Digital Mental Health Interventions
  • Forensic Toxicology and Drug Analysis
  • Schizophrenia research and treatment
  • Treatment of Major Depression
  • Attention Deficit Hyperactivity Disorder
  • Health Policy Implementation Science
  • HIV/AIDS Research and Interventions
  • Alcohol Consumption and Health Effects
  • Interprofessional Education and Collaboration
  • Mental Health Treatment and Access
  • Hepatitis B Virus Studies
  • Gambling Behavior and Treatments
  • Pain Management and Opioid Use
  • Psychedelics and Drug Studies
  • Child and Adolescent Psychosocial and Emotional Development
  • Alcoholism and Thiamine Deficiency

Université de Montréal
2016-2025

Centre Hospitalier de l’Université de Montréal
2016-2025

British Lung Foundation
2022-2024

Multi Electrical System (Suriname)
2022-2024

Dà-Jiāng Innovations Science and Technology (China)
2022-2024

University of Alberta
2023

Canadian Institutes of Health Research
2017-2023

Instituto Superior de Ciencias Sociais e Relações Internacionais
2023

King Abdulaziz University
2023

Centre for Addiction and Mental Health
2023

ABSTRACT Aims To examine trends in prescription opioid (PO) injection and to assess its association with hepatitis C virus (HCV) seroconversion among drug users (IDUs). Design Prospective cohort study. Setting Montreal, Canada. Participants HCV‐negative IDUs at baseline, reporting the past month. Measurements Semi‐annual visits included HCV antibody testing an interview‐administered questionnaire assessing risk behaviours. incidence rate was calculated using person–time method. Time‐updated...

10.1111/j.1360-0443.2012.03803.x article EN Addiction 2012-01-16

Objectives: Cannabidiol (CBD) is hypothesized as a potential treatment for opioid addiction, with safety studies an important first step medication development. We determined CBD and pharmacokinetics when administered concomitantly high-potency in healthy subjects. Methods: This double-blind, placebo-controlled cross-over study of CBD, coadministered intravenous fentanyl, was conducted at the Clinical Research Center Mount Sinai Hospital, tertiary care medical center New York City....

10.1097/adm.0000000000000118 article EN Journal of Addiction Medicine 2015-03-06

The use of social robots as innovative therapeutic tools has been increasingly explored in recent years an effort to address the growing need for alternative intervention modalities mental health care.The aim this scoping review was identify and describe robot interventions facilities highlight their outcomes well barriers facilitators implementation.A literature published since 2015 conducted using Arksey O'Malley's framework. MEDLINE, Embase, Cochrane Central Register Controlled Trials,...

10.2196/36094 article EN cc-by JMIR Mental Health 2022-04-19

Objective: Extensive exposure to prescription-type opioids has resulted in major harm worldwide, calling for better-adapted approaches opioid agonist therapy. The authors aimed determine whether flexible take-home buprenorphine/naloxone is as effective supervised methadone reducing use consumers with disorder. Methods: This seven-site, pan-Canadian, 24-week, pragmatic, open-label, noninferiority, two-arm parallel randomized controlled trial involved treatment-seeking adults Participants were...

10.1176/appi.ajp.21090964 article EN American Journal of Psychiatry 2022-06-15

KEY POINTS In October 2018, Canada was the first G-20 nation to implement legalization of nonmedical cannabis use and supply for adults.[1][1] Cannabis in had primary objectives improving cannabis-related public health safety; reducing youth access cannabis;

10.1503/cmaj.230808 article EN cc-by-nc-nd Canadian Medical Association Journal 2023-10-09

<sec> <title>BACKGROUND</title> Canada’s legalization of recreational cannabis use (CU) has made even more evident the need for innovative interventions promoting lower-risk CU. Young adults 18 to 25 are age group with highest prevalence Protective behavioral strategies (PBS) have been proven help manage CU and reduce negative consequences. To date, few focused on PBS. fill this gap, a mobile application (app) prototype using PBS as means influencing was developed young adults. </sec>...

10.2196/preprints.71924 preprint EN cc-by 2025-01-31

ABSTRACT Background and Aims Cocaine use disorder (CUD) is a significant public health concern for which no efficacious pharmacological interventions are available. Cannabidiol (CBD) has attracted considerable interest as promising treatment addiction. This study tested CBD efficacy reducing craving preventing relapse in people with CUD. Design Single‐site double‐blind randomized controlled superiority trial comparing placebo. Setting Participants Centre Hospitalier de l'Université Montréal,...

10.1111/add.15417 article EN cc-by-nc-nd Addiction 2021-01-19

The high prevalence of cannabis use among young adults poses substantial global health concerns due to the associated acute and long-term psychosocial risks. Digital modalities, including websites, digital platforms, mobile apps, have emerged as promising tools enhance accessibility availability evidence-based interventions for use. However, existing reviews do not consider specifically, combine cannabis-related outcomes with those many other substances in their meta-analytical results, solely target

10.2196/55031 article EN cc-by Journal of Medical Internet Research 2024-03-09

Notification of hepatitis C virus (HCV) positive status is known to have short-term impacts on subsequent alcohol, drug use and injection behaviors among persons who inject drugs (PWID). It remains be established whether postscreening behavioral changes extend over time for PWID screening test notification has HCV-negative PWID. This study sought longitudinally assess substance after HCV seroconverters PWID.Initially HCV-seronegative (n = 208) were followed prospectively between 2004 2011 in...

10.1093/cid/cit938 article EN Clinical Infectious Diseases 2013-12-20

Cannabis is the most commonly used non-legal drug, especially among young people. In 2018, Canada implemented legalization of non-medical cannabis use and supply for adults.1Fischer B. Jutras-Aswad D. Hall W. Outcomes associated with nonmedical policy in Canada: taking stock at 5-year mark.CMAJ. 2023; 195: E1351-E1353Crossref PubMed Scopus (4) Google Scholar This reform was framed by multiple primary objectives, which included improved public health, safety youth protection, specifically...

10.1016/j.lana.2024.100773 article EN cc-by-nc The Lancet Regional Health - Americas 2024-05-17

LGBTQIA2S + populations are believed to be at higher risk of problem gambling due their elevated rates mental disorders and substance abuse compared heterosexual cisgender populations. However, little is known about these regarding practices in the Canadian context. We conducted an online survey among residents 18 years or older who self-identify as sexually gender-diverse (i.e., ) have gambled least once preceding year (N = 1,519). used descriptive analysis portray sample's habits a...

10.1016/j.addbeh.2025.108257 article EN cc-by-nc-nd Addictive Behaviors 2025-01-10
Coming Soon ...